Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Prospective clinical evaluation of lower cut‐offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients

Maertens, Johan, Theunissen, Koen, Verbeken, Eric, Lagrou, Katrien, Verhaegen, Jan, Boogaerts, Marc, Eldere, Johan Van·2004·British Journal of Haematology

Abstract

Summary: The recent advent of an improved commercial serum enzyme‐linked immunosorbent assay (ELISA) for the detection of circulating galactomannan (GM), a major constituent of Aspergillus cell walls, has contributed to the diagnosis of invasive aspergillosis (IA) in many haematology and transplant centres. However, the optimal threshold for positivity remains a matter of debate. We prospectively evaluated the impact of lowering the cut‐off in 124 neutropenic episodes with a high pretest probability for IA. Two new cut‐off points, lower than previously accepted, are proposed: (a) a ‘static’ cut‐off at 0·8 and (b) a ‘dynamic’ cut‐off at 0·5. A single assay with an optical density (OD) index ≥0·8 warrants the initiation of anti‐Aspergillus therapy. A further lowering of the ‘static’ threshold seems not clinically feasible given the drop in positive predictive value (PPV). However, the demonstration of at least two sequential sera with an OD ≥0·5 (‘dynamic’ threshold) increased the specificity and the PPV to 98·6% and the efficiency to 98%. Applying both cut‐offs to a subgroup of 21 ‘possible’ fungal infections further identified and upgraded six cases of IA. However, the clinical benefit of lower cut‐offs (particularly for earlier diagnosis) depends upon the kinetics of antigenaemia and the intensity of serum sampling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.2004.05140.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 169

Metadata

Authors
Maertens, J., Theunissen, K., Verbeken, E., Lagrou, K., Verhaegen, J., Boogaerts, M., & Eldere, J. V.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2004-08-16
Volume
126
Issue
6
Pages
852-860
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W1973212888
Cited by
169
References
4
FWCI
11.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prospective clinical evaluation of lower cut‐offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. https://app.cochat.ai/papers/10.1111/j.1365-2141.2004.05140.x
The paper
Maertens, J., Theunissen, K., Verbeken, E., Lagrou, K., Verhaegen, J., Boogaerts, M., & Eldere, J. V. (2004). Prospective clinical evaluation of lower cut‐offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2004.05140.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.